Concepedia

Author

D. Hueppe

Center for HIV and Hepatogastroenterology

Also Known As

D Hueppe, D. Hueppe, Dietrich Hueppe

101

Publications

948

Citations

14

H-Index

15

Concepts

All Affiliations

Center for HIV and HepatogastroenterologyKlinikum LeverkusenUniversität HamburgUniversity Medical Center Hamburg-EppendorfUniversity Hospital Bonn
DH

About

D. Hueppe is an author at Center for HIV and Hepatogastroenterology specializing in hepatitis b, hepatitis, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

185

2

Hepatology

4

4

185

3

Epidemiology

2

2

83

4

Public Health

1

1

29

5

Nephrology

1

1

86

D. Hueppe

×

13

Publications

605

Citations

13

H-Index

YearCitations

Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B

Stefan Mauss, F. Berger, Natalie Filmann,

Journal of Hepatology

2011

86

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Stefan Mauss, D. Hueppe, U. Alshüth

Hepatology

2013

83

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Patrick Ingiliz, Stefan Christensen, Torben Kimhofer,

Clinical Infectious Diseases

2016

72

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Patrick Ingiliz, Malte H. Wehmeyer, Christoph Boesecke,

Clinical Infectious Diseases

2019

69

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Jörg Petersen, R Heyne, Stefan Mauss,

Digestive Diseases and Sciences

2015

54

High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection

Johann von Felden, Johannes Vermehren, Patrick Ingiliz,

Alimentary Pharmacology & Therapeutics

2018

53

Effect of Antiviral Therapy for HCV on Lipid Levels

Stefan Mauss, F. Berger, Malte H. Wehmeyer,

Antiviral Therapy

2016

48

Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

T. Witthoeft, D. Hueppe, C John,

Journal of Viral Hepatitis

2010

31

Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

S. Mauss, D. Hueppe, C John,

Journal of Viral Hepatitis

2010

29

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Malte H. Wehmeyer, Patrick Ingiliz, Stefan Christensen,

Journal of Medical Virology

2017

27

Page 1